The retrospective analysis of patients with uterine sarcomas: A single-center experience.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Cancer Research and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0973-1482.148698PMID 27072256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Uterine Sarcomas - a review].

  2012influential reference
• Clinical outcome of patients with uterine sarcomas.

  2011cited by this paper
• Current management of uterine sarcomas

  2011cited by this paper
• Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium”

  2010cited by this paper
• Uterine sarcomas: a review.

  2010cited by this paper
• Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.

  2009cited by this paper
• Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

  2009cited by this paper
• Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

  2009cited by this paper
• Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007

  2008cited by this paper
• Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

  2008cited by this paper
• Prognostic Features of Surgical Stage I Uterine Carcinosarcoma

  2007cited by this paper
• A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

  2007cited by this paper
• Carcinosarcomas--a retrospective analysis of 21 patients.

  2006cited by this paper
• Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

  2004cited by this paper
• Uterine sarcoma: twenty-seven years of experience.

  2003cited by this paper
• Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy

  2003cited by this paper
• Endometrial Stromal Nodules and Endometrial Stromal Tumors With Limited Infiltration: A Clinicopathologic Study of 50 Cases

  2002cited by this paper
• Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

  2001cited by this paper
• Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

  2000cited by this paper
• Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

  1997cited by this paper
• Primary Uterine Endometrial Stromal Neoplasms: A Clinicopathologic Study of 117 Cases

  1990cited by this paper
• The epidemiology of sarcomas of the uterus.

  1986cited by this paper

• Prognostic factors and survival outcomes of uterine sarcomas in a reference gynecologic oncology cancer center

  2021cites this paper
• RETROSPECTIVE ANALYSIS OF UTERINE CARCINOSARCOMA FROM A TERTIARY CARE CENTRE IN SOUTH INDIA

  2020cites this paper
• Outcomes of patients with pelvic leiomyosarcoma treated by surgery and relevant auxiliary diagnosis

  2020cites this paper
• Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in Uterine Sarcoma

  2020cites this paper
• Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study

  2019cites this paper
• POJAVNOST I PREŽIVLJENJE OBOLJELIH OD SARKOMA MATERNICE U KBC-u SPLIT U RAZDOBLJU OD 1993. DO 2018. GODINE

  2018influential citation